(Q67924004)

English

Intractable heart failure despite angiotensin-converting enzyme inhibitors, digoxin, and diuretics: Long-term effectiveness of add-on therapy with pimobendan

scientific article published on 01 August 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1858635%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Intractable heart failure despite angiotensin-converting enzyme inhibitors, digoxin, and diuretics: long-term effectiveness of add-on therapy with pimobendan (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1858635%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Intractable heart failure despite angiotensin-converting enzyme inhibitors, digoxin, and diuretics: Long-term effectiveness of add-on therapy with pimobendan (English)

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

1 reference

based on heuristic

inferred from title

Cardiology and cardiovascular medicine

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

author name string

F. Hagemeijer

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1858635

11 December 2022

language of work or name

0 references

publication date

1 August 1991

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1858635%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

full work available at URL

https://api.elsevier.com/content/article/PII:000287039191010K?httpAccept=text/xml

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

https://api.elsevier.com/content/article/PII:000287039191010K?httpAccept=text/plain

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

American Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1858635%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

122

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1858635%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1858635%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

517-522

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1858635%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

UD-CG 115 ? a cardiotonic pyridazinone which elevates cyclic AMP and prolongs the action potential in guinea-pig papillary muscle

1

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Cardiac and coronary vasodilator profile of pimobendan, a new cardiotonic drug, revealed by use of isolated, blood-perfused dog heart preparations

4

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Cardiovascular effects of UD-CG 212 CL, a metabolite of pimobendan, in anaesthetized pigs

7

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Systemic haemodynamic actions of pimobendan (UD-CG 115 BS) and its O-demethylmetabolite UD-CG 212 Cl in the conscious pig.

8

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Cardiac electrophysiologic and hemodynamic activity of pimobendan (UD-CG 115 BS), a new inotropic agent

9

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Influence of enoximone and UDCG-115 on coronary hemodynamics in idiopathic dilated cardiomyopathy.

12

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Pimobendane (UD-CG 115 BS) in chronic congestive heart failure. Short-term and one-month effects of a new inotropic vasodilating agent

13

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Pimobendane (UD-CG 115 BS) in the treatment of severe congestive heart failure. An acute haemodynamic cross-over and double-blind study with two different doses

14

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Hemodynamic effects of pimobendan given orally in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

17

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Cardiovascular effects and plasma level profile of pimobendan (UD-CG 115 BS) and its metabolite UD-CG 212 in patients with congestive heart failure after single and repeated oral dosing

18

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Inotropic drugs and their mechanisms of action

23

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Effects of new inotropic agents on Ca++ sensitivity of contractile proteins

24

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Influence of association and of positive inotropic drugs on calcium binding to cardiac troponin C

25

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Sensitization of dog and guinea pig heart myofilaments to Ca2+ activation and the inotropic effect of pimobendan: comparison with milrinone

27

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

The positive inotropic effect of pimobendan involves stereospecific increases in the calcium sensitivity of cardiac myofilaments

28

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Calcium sensitisers

29

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combinations in patients with severe heart failure

30

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group

31

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

32

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Clinical, haemodynamic, and antiarrhythmic effects of long term treatment with amiodarone of patients in heart failure

34

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation

35

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Approaches to sudden death from coronary heart disease

37

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Lung Changes in Left Heart Failure

38

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

International diagnostic criteria for acute myocardial infarction and acute stroke

39

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure

40

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure

41

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group

42

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Cardiac failure and sudden death in the Framingham Study

44

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy

45

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity

46

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Do vasodilators prolong life in heart failure?

47

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Mode of death in idiopathic dilated cardiomyopathy: a multivariate analysis of prognostic determinants.

49

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Cyclic adenosine monophosphate, ventricular fibrillation, and antiarrhythmic drugs

51

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Electrophysiology of phosphodiesterase inhibitors

52

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Ventricular arrhythmias in severe heart failure: incidence, significance, and effectiveness of antiarrhythmic therapy

53

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Determinants of survival in patients with malignant ventricular arrhythmia associated with coronary artery disease

54

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Cardiovascular effects of sulmazol administered intravenously to patients with severe heart failure

55

1 reference

10.1016/0002-8703(91)91010-K

https://api.crossref.org/works/10.1016/0002-8703(91)91010-K

11 December 2022

Identifiers

10.1016/0002-8703(91)91010-K

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1858635%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1858635%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q67924004&oldid=1787975174"